Ozempic 1 MG/dose (4 MG/3 ML) 3ML
Ended Awarded Last action
- Contract number
- SPE2DR26F65N4
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $12,382
Award facts
- Contract value 100% obligated
- $12,382.44 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to Amerisourcebergen Drug Corp (a subsidiary of Cencora, Inc.) on January 13, 2026, for the supply of Ozempic 1 mg/dose (4 mg/3 mL) 3 mL vials, with a ceiling value of $12,382.44 and an ultimate completion date of January 14, 2026. This is a firm fixed-price delivery order with no set-aside designation, meaning it was competitively awarded. The place of performance is Conshohocken, Pennsylvania, where Amerisourcebergen Drug Corp's corporate office is headquartered. This delivery order is issued under Amerisourcebergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs.
Amerisourcebergen Drug Corp, as a major pharmaceutical distributor and critical vendor for federal medical procurement, supplies a broad portfolio of brand-name and generic medications, vaccines, and medical supplies across multiple therapeutic domains to support military and veteran healthcare systems. The parent company, Cencora, Inc., holds an even larger IDC with the DLA Troop Support Medical valued at up to $999,999,999.00 through December 31, 2031. The delivery of Ozempic, a diabetes management medication, reflects the company's role in supporting the Defense Health Agency and other federal healthcare systems with essential pharmaceutical commodities.
Quick answers
Who was awarded contract SPE2DR26F65N4?
SPE2DR26F65N4 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 13, 2026.
How much is contract SPE2DR26F65N4 worth?
The government has obligated $12,382 on SPE2DR26F65N4.
Is contract SPE2DR26F65N4 an order under another contract?
Yes. SPE2DR26F65N4 is a delivery order under SPE2DR25D3303, an indefinite delivery contract.
Was contract SPE2DR26F65N4 competed?
The extent of competition for SPE2DR26F65N4 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award